NDATF (NDatalyze) Common Stock: $2.14 Mil (As of Feb. 2026)


What is NDatalyze Common Stock?

NDatalyze NDATF Common Stock is $2.14 Mil as of Feb. 2026.

NDatalyze's quarterly common stock declined from Aug. 2025 ($2.11 Mil) to Nov. 2025 ($2.08 Mil) but then increased from Nov. 2025 ($2.08 Mil) to Feb. 2026 ($2.14 Mil).

NDatalyze's annual common stock increased from Feb. 2024 ($1.98 Mil) to Feb. 2025 ($2.04 Mil) and increased from Feb. 2025 ($2.04 Mil) to Feb. 2026 ($2.14 Mil).

NDatalyze Common Stock Historical Data

* Premium members only.

The historical data trend for NDatalyze's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDatalyze Common Stock Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Common Stock
Get a 7-Day Free Trial 1.78 1.82 1.98 2.04 2.14

NDatalyze Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 2.10 2.11 2.08 2.14

NDatalyze Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $2.14 Mil mean?
NDatalyze (NDATF) has a Common Stock of $2.14 Mil as of Feb. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on NDatalyze and its competitors.
Is NDatalyze's Common Stock too high?
NDatalyze's current Common Stock is $2.14 Mil.
How does NDatalyze's Common Stock compare to VEEV and BTSG?
NDatalyze's Common Stock of $2.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on NDatalyze and its competitors. NDatalyze's current Common Stock is $2.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
Based on GuruFocus' analysis, NDatalyze (NDATF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Common Stock is $2.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For NDatalyze (NDATF), the current Common Stock is $2.14 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NDatalyze Business Description

Other Exchanges NDAT:Canada
Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.